publications

2025/In Press

1.  Whearty*, K.M., Ruiz*, I., Knippenberg*, AR., Strauss, G.P. (in press). Anhedonia reflects an encoding deficit for pleasant stimuli in schizophrenia: Evidence from the emotion-induced memory trade-off eye tracking paradigm. Neuropsychology.

2. Strauss, G.P., Knippenberg*, A.R., Allen, D.N. (in press). Anhedonia is associated with impaired memory for positive emotional stimuli in schizophrenia. Neuropsychology.

3. Luther*, L., Ahmed, A.O., Grant, P.M., Granholm, E., Gold, J.M., Williams, T.F., Pratt, D., Holden, J., Walker, E.F., Arnold*, L., Ellman, L.M., Mittal, V.A., Zinbarg, R., Silverstein, S.M., Corlett, P.R., Powers, A.R., Woods, S.W., Waltz, J.A., Schiffman, J., & Strauss, G.P. (in press). Revisiting the Defeatist Performance Belief Scale in Adults with Schizophrenia and Youth at Clinical-High Risk for Psychosis: A Comprehensive Psychometric Analysis. Schizophrenia Bulletin.

4. Luther*, L., Raugh*, I.M., & Strauss, G.P. (in press). Probabilistic Reinforcement Learning Impairments Predict Negative Symptom Severity and Risk for Conversion in Youth at Clinical High-Risk for Psychosis. Psychological Medicine.

5. Ibonie, S. G., Young, G., Ploe, M. L., Mauss, I. B., Alloy, L., Bavel, J. V., Borelli, J. L., Bullock, B., Holley, S. R., Jopling, E., Kamble, S., LeMoult, J., Mason, L., Moriarty, D., Nusslock, R., Okuma, A., Rutledge, R. B., Strauss, G.P,  Villanueva, C. M., & Gruber, J. (in press). Associations Between Bipolar Risk with Social Networks Dimensions in Emerging Adults: two social sides of bipolar disorder. Journal of Clinical and Social Psychology.

6. Spilka*, M. J., Millman, Z. B., Waltz, J. A., Walker, E. F., Levin*, J. A., Powers, A. R., Corlett, P. R., Schiffman, J., Gold, J. M., Silverstein, S. M., Ellman, L. M., Mittal, V. A., Woods, S. W., Zinbarg, R., & Strauss, G. P. (in press). A generalized reward processing deficit pathway to negative symptoms across diagnostic boundaries. Psychological Medicine.

7. Raugh*, I.M., Strauss, G.P. (In press). Deconstructing emotion regulation in schizophrenia: The nature and consequences of positive emotion up-regulation abnormalities. Journal of Emotion and Psychopathology.

8. Strauss, G.P., Raugh*, I.M., Visser*, K.F., Walker, E.F., Mittal, V.A. (In press). Deconstructing the nature of emotion regulation impairments at the identification, selection, and implementation stages in individuals at clinical high-risk for psychosis. Psychological Medicine.

9. Raugh*, I.M., Berglund*, A.M., Strauss, G.P. (in press). Implementation of Mindfulness-Based Emotion Regulation Strategies: A Systematic Review And Meta-Analysis. Affective Science.

10. Strauss, G.P., Walker, E.F., Luther*, L., Mittal, V.A. (in press). The Negative Symptom Inventory-Psychosis Risk (NSI-PR): Psychometric Validation of the Final 11-item version. Schizophrenia Bulletin.

11. Zollicoffer*, A.N., Strauss, G.P., Luther*, L., Schiffman, J., Sims, B., Li, H. (2025). The relationship between perceived family support and subclinical positive symptoms of psychosis among Black college students. Early Intervention in Psychiatry, 19(1):e13554.

12. Weiss*, B., Dinh-Williams, L.L., Beller, N., Raugh*, I.M., Strauss, G.P., Campbell, W.K. (in press). Ayahuasca in the treatment of Post-traumatic Stress Disorder: Mixed methods case series evaluation in military combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy.

13.  Zhang*, L., James*, S.H., Standridge, J., Condray, R., Allen, D.N., Strauss, G.P. (in press). Social network reductions are associated with negative symptoms in schizophrenia. Social Psychiatry and Psychiatric Epidemiology.

14. Bartolomeo*, L.A., Strauss, G.P. (in press). Unpacking the anhedonia paradox across the psychosis continuum: The role of the positivity offset. Journal of Emotion and Psychopathology.

15. Kuhney*, F.S, Strauss, G.P., Walker, E.F., James*, S.H., Mittal, V.A. (in press). Digital Phenotyping Measurements of Smartphone Social Behavior Predict Illness Progression Risk Scores in Young People at Clinical High-Risk for Psychosis. Schizophrenia Bulletin.

16. Pokorny, V., Tran, T., Williams, T. F., Kenney, J., Silverstein, S. M., Gold, J. M., Waltz, J. A., Schiffman, J., Ellman, L. M., Strauss, G. P., Walker, E. F., Woods, S. W., Powers, A. R., Corlett, P. R., & Mittal, V. A. (in press). Functional Correlates of Atypical Visuoperceptual Organization in a Multisite Clinical High Risk Sample. Journal of Psychopathology and Clinical Science.

17. Luther*,  L., Zhang*, Z., James*, S.H., Zhang*, L., Standridge, J., Arnold*, L.,  Condray, R., Allen, D.N., & Strauss, G.P. (in press). Resource  deprivation in the home environment is associated with negative symptoms  in outpatients with schizophrenia. Schizophrenia.

18. Tran, T., Keane, B., Thompson, J., Robinson, B., Kenney, J., Williams, T., Waltz, J.A., Levin*, J., Kafadar, E., Gold, J.M., Schiffman, J., Ellman, L., Walker, E.F., Strauss, G.P., Mittal, V.A., Zinbarg, R., Corlett, P.,. Powers, A., Woods, S., Silverstein, S. (In Press). Increased Face Perception in Idividuals at Clinical High-Risk for Psychosis: Mechanisms, Sex Differences, and Clinical Correlates. Schizophrenia.

19. Goldsmith DR, Ning CS, Strauss GP, Gross RE, Cooper JA, Wommack EC, Haroon E, Felger JC, Walker EF, Treadway MT, Miller AH (2025). Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia. Neuropsychopharmacology.

20. Bailey A, Bauer BW, Mittal VA, Ellman LM, Strauss GP, Walker EF, Powers AR, Kenney J, Corlett PR, Woods SW, Gold JM, Silverstein, S. (2025) Interpersonal difficulties and suicidal ideation in young people at clinical high-risk for psychosis and help-seeking clinical controls. Psychiatry Research;348:116467.

21.  Bartolomeo*, L.A., James*, S.H., Berglund*, A.M., Raugh, I.M., Mittal, V.A., Walker, E,F., Strauss, G.P. (in press). Digital phenotyping evidence for the reduced positivity offset as a mechanism underlying anhedonia among individuals at clinical high-risk for psychosis. Schizophrenia Research. 

22. Allott, K., Yassin, W., Alameda, L.,  Billah, T., Borders, O., Buccilli, K., ... & Stone, W. S. (2025).  Cognitive assessment in the Accelerating Medicines Partnership®  Schizophrenia Program: Harmonization priorities and strategies in a  diverse international sample. Schizophrenia, 11(1), 49.

23. Mathalon et al. (in press). The Electroencephalography Protocol for the AMP SCZ Consortium: Reliability and Stability of Measures. Schizophrenia.

24. Wigman et al. (in press). Digital Health Technologies in The Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia.

25. Addington et al. (in press). Sample Ascertainment and Clinical Outcome Measures in the AMP SCZ Study. Schizophrenia.

26. Harms, M. P., Cho, K. I. K.,  Anticevic, A., Bolo, N. R., Bouix, S., Campbell, D., ... &  Pasternak, O. (2025). The MR Neuroimaging Protocol for the Accelerating  Medicines Partnership® Schizophrenia Program. Schizophrenia, 11(1), 52.

2024

1. Knippenberg*, A.R, Yavari*, S., Strauss, G.P. (2024). Negative auditory hallucinations are associated with increased activation of the defensive motivational system in schizophrenia. Schizophrenia Research: Cognition, 39:100334.

2. James*, S.H., Ahmed, A.O., Harvey, P.D., Saoud, J.B., Davidson, M., Kuchibhatla, R., Luthringer, R., Strauss GP. (2024). Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition. European Neuropsychopharmacology, 87, 18-23.

3. Luther*, L., Raugh*, I.M., Grant, P.M., Beck, A.T., Strauss, G.P. (2024). The Role of Defeatist Performance Beliefs in State Fluctuations of Negative Symptoms in Schizophrenia Measured in Daily Life via Ecological Momentary Assessment. Schizophrenia Bulletin, 50(6), 1427-1435.

4. Alliende, L.M.; Strauss, G.P.; Yang, L; Mittal, V.A. (2024). Perceptions of Stigma in Youth at Clinical High Risk for Psychosis and Depressive Symptomatology. Schizophrenia Research, 269:79-85.

5. Rossi-Goldthorpe R, Silverstein SM, Gold JM, Schiffman J, Waltz JA, Williams TF, Powers AR, Woods SW, Zinbarg RE, Mittal VA, Ellman LM., Strauss, G.P., Walker, E.F., Levin, J.A., Castiello, S., Kenney, J., Corlett, P.R.  (2024). Different learning aberrations relate to delusion-like beliefs with different contents. Brain, 147(8):2854-2866.

6. Pratt, D. N., Treadway, M. T., Strauss, G. P., Mittal, V. A. (2024). Diminished Differentiation of Rewards in Individuals at Clinical High-Risk for Psychosis. European Archives of Psychiatry and Clinical Neuroscience, 274(6):1437-1445.

7. Wannan, C.M.J. et al. (2024). AMP SCZ: Rationale and study design of the largest global prospective cohort study of clinical high-risk for psychosis. Schizophrenia Bulletin,50, 496-512.

8. Luther*, L., Jarvis*, S.A., Spilka*, M.J., & Strauss, G.P. (2024). Global reward processing deficits predict negative symptoms transdiagnostically and transphasically in a severe mental illness-spectrum sample. European Archives of Psychiatry and Clinical Neuroscience, 274(7):1729-1740.

9. Cowan, T., Rodriguez, Z., Strauss, G.P.,Raugh*, I.M., Cohen, A.S. (2024). Computerized analysis of facial expression reveals objective indices of blunted facial affect: A short communication. European Archives of Psychiatry and Clinical Neuroscience, 274(7):1771-1775.

10. Strauss, G.P.(2024). Environmental factors contributing to negative symptoms in youth at clinical high-risk for psychosis and outpatients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 59(7):1167-1175.

11. Raugh*, I.M., Strauss, G.P. (2024). Integrating Mindfulness Into The Extended Process Model Of Emotion Regulation: The Dual-Mode Model Of Mindful Emotion Regulation. Emotion, 24(3), 847-866.

12. Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Marcy PJ, Allott K, Amminger P, Arango C, Broome MR, Cadenhead KS, Chen EYH, Choi J, Conus P, Cornblatt BA, Glenthøj LB, Horton LE, Kambeitz J, Kapur T, Keshavan MS, Koutsouleris N, Langbein K, Lavoie S, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pasternak O, Pearlson GD, Gaspar PA, Shah JL, Smesny S, Stone WS, Strauss GP, Wang J, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR 3rd, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, Yung AR (2024). Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. Early Intervention in Psychiatry, 18(4):255-272.

13. James*, S.H., Strauss, G.P. (2024). Racial differences in attenuated psychotic symptoms during the COVID-19 pandemic. Early Intervention in Psychiatry, 18(2), 165-169.

2023

1. Luther*, L., Westbrook, A., Ayawvi*, G., Ruiz*, I., Raugh*, I.M., Chu, A.O.K., Chang, W.C., Strauss, G.P. (2023). The role of defeatist performance beliefs in effort-cost decision-making in schizophrenia. Schizophrenia Research, 261, 216-224.

2. Pratt, D. N., Luther, L., Kinney, K. S., Osborne, K. J., Corlett, P. R., Powers, A. R., Woods, S. W., Gold, J. M., Schiffman,  J., Ellman, L. M., Strauss, G. P., Walker, E. F., Zinbarg, R., Waltz, J. A., Silverstein, S. M.,  & Mittal, V. A (2023). Comparing a Computerized Digit Symbol Test to a Pen-And-Paper Classic. Schizophrenia Bulletin Open, 4(1), sgad027.

3. Zhang*, L., James*, S.H., Strauss, G.P. (2023). Environmental resource reductions predict greater severity of negative symptoms in schizophrenia. Schizophrenia Research, 261, 94-99.

4. Raugh*, I.M., Spilka*, M.J., Luther*, L., Suveg, C.M., Strauss, G.P. (2023). Ecological momentary assessment of state fluctuations in mindfulness and symptoms in psychotic disorders. Journal of Contextual Behavioral Science, 29, 219-229.

5. Strauss, G. P., Esfahlani, F. Z., Raugh*, I. M., Luther*, L., & Sayama, H. (2023). Markov chain analysis indicates that positive and negative emotions have abnormal temporal interactions during daily life in schizophrenia. Journal of Psychiatric Research, 164, 344-349.

6. Tran*, T., Spilka*, M..J., Raugh*, I.M., Strauss, G.P., Bearden, C.E., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Keshavan, M., Mathalon, D.H., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Stone WS, Tsuang MT, Walker EF, Woods SW, Addington JM. (2023). Negative symptom trajectories in individuals at clinical high-risk for psychosis: Differences based on deficit syndrome, persistence, and transition status. Schizophrenia Bulletin: Open, 4, (1), sgad014.

7. Strauss, G.P., Esfahlani-Zamani, F., Raugh*, I.M., Luther*, L., Sayama, H. (2023). Network analysis of discrete emotional states measured via ecological momentary assessment in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 273, 1863-1871.

8. Strauss, G.P., Raugh*, I.M., Luther*, L., Walker, E.F., Mittal, V.A. (2023). Temporal interactions between social motivation and behavior in daily life among individuals at clinical high-risk for psychosis. Schizophrenia Bulletin, 49, 1150-1160.

9. Raugh*, I. M., Bartolomeo*, L. A., Zhang*, L., James*, S. H., Strauss, G. P. (2023). Deconstructing Emotion Regulation In Schizophrenia: The Nature Of Abnormalities At The Selection And Implementation Stages. Journal of Psychopathology and Clinical Science, 132, 908-920.

10. Berglund*, A.M., Raugh*, I.M., Macdonald*, K.I., James*, S.H., Bartolomeo*, L.A., Knippenberg*, A.R., Strauss, G.P. (2023). The Effects of the COVID-19 Pandemic on Hallucinations and Delusions in Youth at Clinical High-Risk for Psychosis and Outpatients with Schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 273, 1329-1338.

11. Raugh*, I.M., Luther*, L., Bartolomeo*, L.A., Gupta, T., Ristanovic, I., Pelletier-Baldelli, A., Mittal, V.A., Walker, E.F., Strauss, G.P. (2023). Negative Symptom Inventory- Self-Report: Initial Development and Validation. Schizophrenia Research, 256, 79-87.

12. Luther*, L., Raugh*, I.M., Collins*, D.E., Berglund*, A., Knippenberg*, A.R., Mittal, V.A., Walker, E.F., Strauss, G.P. (2023). Environmental context predicts state fluctuations in negative symptoms in youth at clinical high risk for psychosis. Psychological Medicine, 53, 7609-7618.

13. Kirkpatrick, B., Luther*, L., Strauss, G.P. (2023). Negative symptoms in the clinic: We treat what we can describe. British Journal of Psychiatry, 223, 271-272.

14.  Cheon, E.J., Male, A.G., Gao, B., Adhikari, B.M., Edmond, J.T., Hare, S.M., Belger, A.I., Potkin, S.G., Bustillo, J.R., Mathalon, D.H., Ford, J.M., Lim, K.O., Mueller, B.A., Preda, A., O'Leary, D.O., Strauss, G.P., Ahmed, A.O., Thompson, P.M., Jahanshad, N., Kochunov, P.R., Calhoun, V.D., Turner, J.A., van Erp, T.G.M. (2023). Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in schizophrenia. Psychiatry Research: Neuroimaging, 111597.

15. Ayawvi*, G., Berglund*, A.M., James*, S.H., Luther*, L., Walker, E.F., Mittal, V.A., Strauss, G.P. (2023). The association between early traumatic experiences and the five domains of negative symptoms in participants at clinical high-risk for psychosis. Early Intervention in Psychiatry, 17, 1131-1135.

16. Strauss, G.P., Walker, E.F., Pelletier-Baldelli, A., Carter, N.T., Ellman, L.M., Schiffman, J., Luther*, L., James*, S.H., Berglund*, A.M., Gupta, T., Ristanovic, I., Mittal, V.A. (2023). Development and Validation of the Negative Symptom Inventory-Psychosis Risk (NSI-PR). Schizophrenia Bulletin, 49, 1205-1216.

17. Williams, T. F., Walker, E. F., Strauss, G. P., Woods, S. W., Powers, A. R., Corlett, P. R., Schiffman, J., Waltz, J. A., Gold, J. M., Silverstein, S. M., Ellman, L. M., Zinbarg, R. E., & Mittal, V. A. (2023). The reliability and validity of the Revised Green et al. Paranoid Thoughts Scale in individuals at clinical high-risk for psychosis. Acta Psychiatrica Scandinavica, 147, 623-633.

188. Luther*, L., Raugh*, I.M., Collins*, D.E., Knippenberg*, A., Strauss, G.P.(2023). Negative symptoms in schizophrenia differ across environmental contexts in daily life. Journal of Psychiatric Research, 161, 10-18. 

18. Berglund*, A.M., James*, S.H., Raugh*, I.M., Strauss, G.P. (2023). Beliefs about the uncontrollability and usefulness of emotion in the schizophrenia-spectrum: Links to emotion regulation and negative symptoms. Cognitive Therapy and Research, 47, 282-294.

19. Fung, V.S.C., Chan, J.C.Y., Wong, S.C.Y., Wong, C.S.M., Kirtley, O., Myin-Germeys, I., Strauss, G.P., Chang, W.C. (2023). Investigation of momentary negative symptoms in patients with early psychosis in daily life: an experience sampling study. Psychiatry Research, 115234.

20. Karp, E.L., Williams, T.F., Ellman, L.M., Strauss, G.P., Walker, E.F., Corlett, P.R., Woods, S.W., Powers, A.R., Gold, J.M., Schiffman, J.E., Waltz, J.A., Silverstein, S.M, & Mittal, V.A. (2023) Self-reported gesture interpretation and performance deficits in individuals at clinical high risk for psychosis. Schizophrenia Bulletin, 49, 746-755.

21. Bartolomeo*, L.A., Raugh*, I.M., Strauss, G.P. (2023). The positivity offset theory of anhedonia in schizophrenia: Evidence for a deficit in daily life using digital phenotyping. Psychological Medicine, 53, 1-9.

22. Paul, N., Strauss, G.P., Barchard, K.A., Woodyatt, J., Allen, D.N. (2023). Two and Five Factor Models of Negative Symptoms are Differentially Associated with Trait Affect, Defeatist Performance Beliefs, and Psychosocial Functioning. European Archives of Psychiatry and Clinical Neuroscience, 273, 1715-1724.

23. Macfie*, W.G., Spilka*, M., Bartolomeo*, L.A., Gonzalez*, C.M., Strauss, G.P. (2023). Emotion Regulation And Social Knowledge In Youth At Clinical High Risk For Psychosis And Outpatients With Chronic Schizophrenia: Associations With Functional Outcome And Negative Symptoms. Early Intervention in Psychiatry, 17, 21-28.

24. Collins*, D., Luther*, L., Raugh,* I.M., Condray, R., Allen, D.N., Strauss, G.P. (2023). Environmental contributions to negative symptoms: Exploring the role of disability benefits and interactions with social, political, and legal exosystems. Schizophrenia Bulletin, 49, 1-4.

25.  Strauss, G.P., Bartolomeo*, L.A., Luther*, L. (2023). Reduced willingness to expend effort for rewards is associated with risk for conversion and negative symptom severity in youth at clinical high-risk for psychosis. Psychological Medicine, 714-721.

2022

1.  Narkhede*, S.M., Luther*, L., Raugh*, I.M., Knippenberg*, A.R., Zamani  Esfahlani, F., Sayama, H., Cohen, A.S., Kirkpatrick, B., Strauss, G.P.  (2022). Machine learning identifies digital phenotyping measures most  relevant to negative symptoms in psychotic disorders: Implications for  clinical trials. Schizophrenia Bulletin, 45, 425-436.

2.  Strauss, G.P., Luther, L., Raugh, I.M., Zhang, L., Chapman, H.C.,  Allen, D.N., Kirkpatrick, B., Cohen, A.S. (2022). Validation of  accelerometry as a digital phenotyping measure of negative symptoms in  schizophrenia. Schizophrenia, 8, 37. 

3.  Cowan, T., Masucci, M. D., Gupta, T., Haase, C. M., Strauss, G. P.,  & Cohen, A. S. (2022). Computerized analysis of facial expressions  in serious mental illness. Schizophrenia Research, 241, 44-51. 

4.  Cowan, T., Cohen, A. S., Raugh*, I. M., & Strauss, G. P. (2022).  Ambulatory audio and video recording for digital phenotyping in  schizophrenia: Adherence & data usability. Psychiatry Research, 311,  114485 

5.  Cowan, T., Strauss, G. P., Raugh*, I. M., Le, T. P., & Cohen, A. S.  (2022). How do social factors relate to blunted facial affect in  schizophrenia? A digital phenotyping study using ambulatory video  recordings. Journal of Psychiatric Research, 150, 96-104.

6.  Gupta, T., Haase, C.M., Strauss, G.P., Cohen, A.S., Ricard, J.R.,  Mittal, V.A. (2022). Alterations in facial expressions of emotion:  Determining the promise of ultra-thin slicing approaches and comparing  human and automated coding methods in psychosis risk. Emotion, 22, 714-724.

7.  Cohen, A.S., Rodriguez, Z., Warren, K.K., Cowan, T.M., Masucci, M.D.,  Ganrud, E., Holmlund, T.B., Chandler, C., Foltz, P.W., Strauss, G.P. (2022). Natural language processing and psychosis: On the need for  comprehensive psychometric evaluation. Schizophrenia Bulletin, 48, 939-948. 

8.  Miller, M. L., Raugh,* I. M., Strauss, G. P., & Harvey, P. D.  (2022). Remote Digital Phenotyping in Serious mental Illness: Focus on  Negative Symptoms, Mood Symptoms, and Self-Awareness. Biomarkers in  Neuropsychiatry, 100047.  

9.  Harvey, P.D., Rizzo, S., Strauss, G.P., Nemeroff C.B., Kalin, N.,  Mcdonald, W.M., Krystal, J., Rodriguez, C., Widge, A., Torous, J..,  Carpenter, L. (2022). Technology and mental health: State of the art  for assessment and treatment. American Journal of Psychiatry, 179, 897-914.

10.  Browne, J., Harvey, P.D., Buchanan, R.W., Kelly, D.L., Strauss, G.P.,  Gold, J.M., Holden, J.L. Granholm, E., (2022). A Longitudinal  Examination of Real-World Sedentary Behavior in Adults with  Schizophrenia-Spectrum Disorders in a Clinical Trial of Combined  Oxytocin and Cognitive Behavioral Social Skills Training. Behavioral  Sciences, 12(3), 60. 

11.  Davidson, M., Saoud, J., Staner, C., Noel, N., Werner, S., Luthringer,  E., Walling, D., Weiser, M., Harvey, P.D., Strauss, G.P., Luthringer,  R., (2022). Efficacy and Safety of Roluperidone for the Treatment of  Negative Symptoms of Schizophrenia. Schizophrenia Bulletin, 48, 609-619.

12.  Ahmed, A. O., Kirkpatrick, B., Granholm, E., Rowland, L. M., Barker, P.  B., Gold, J. M., ... & Strauss, G. P. (2022). Two Factors, Five  Factors, or Both? External Validation Studies of Negative Symptom  Dimensions in Schizophrenia. Schizophrenia bulletin, 48, 620-630. 

13.  Paul, N.B., Strauss, G.P., Woodyatt, J.J., Paul, M.G., Keene, J.R.,  Allen, D.N. (2022). Cluster analysis of negative symptoms identifies  distinct negative symptom subgroups. Schizophrenia Research, 246, 207-215.

14. Sabe, M., Chen, C., Perez, N., Solmi, M., Mucci, A., Galderisi, S., Strauss, G.P., Kaiser, S. (2022). Thirty years of research on negative symptoms of schizophrenia: A scientometric analysis of hotspots, bursts, and research trends. Neuroscience & Biobehavioral Reviews, 144, 104979.

15.  Tran*,  T., Spilka*, M. J., Ruiz*, I., & Strauss, G. P. (2022). Implicit  cognitive effort monitoring impairments are associated with expressive  negative symptoms in schizophrenia. Schizophrenia Research, 248, 14-20.

16.  James*, S. H., Berglund*, A., Chang, W. C., & Strauss, G. P. (2022). Discrepancies between ideal and actual affect in schizophrenia: Implications for understanding negative symptoms. Journal of Psychiatric Research, 155, 313-319. 

17.   Spilka*, M. J., Keller, W. R., Buchanan, R. W., Gold, J. M., Koenig, J.  I., Strauss, G. P. (2022). Endogenous oxytocin levels are  associated with facial emotion recognition accuracy but not gaze  behavior in individuals with schizophrenia. Acta Psychiatrica  Scandinavica, 145, 494-506. 

18.  Raugh*, I.M., Strauss, G.P. (2022). Deconstructing emotion  regulation in schizophrenia: The nature and consequences of  abnormalities at the identification stage. European Archives of  Psychiatry and Clinical Neuroscience, 272, 1061-1071.

19.   Bartolomeo*, L. A., Raugh*, I. M., & Strauss, G. P. (2022).  Deconstructing emotion regulation in schizophrenia: The nature and  consequences of abnormalities in monitoring dynamics. Schizophrenia Research, 240, 135-142. 

20.  Turner, J.A., Calhoun, V.D., Thompson, P.M., Jahanshad, N., Ching,  C.R., Thomopoulos, S.I., Verner, E., Strauss, G.P., Ahmed, A.O., Turner,  M.D. and Basodi, S., (2022). ENIGMA+ COINSTAC: improving findability,  accessibility, interoperability, and re-usability. Neuroinformatics,  20, 261-275. 

21.  Macdonald*, K.I., Spilka*, M.J., Bartolomeo*, L.A., Raugh*, I.M.,  Berglund*, A.M., Strauss, G.P. (2022). Adherence to recommended  health and social distancing precautions during the COVID-19 pandemic in  individuals with schizophrenia and youth at clinical high-risk for  psychosis. Schizophrenia Research, 243, 446-448.   

22.  Zhang*, L., & Strauss, G.P. (2022). Adaptive and maladaptive  consequences of increased social media and internet use during the  COVID-19 pandemic in schizophrenia. Schizophrenia Research, 243, 472-474. 

23. Tran*, T., Holland*, A. H., Zhang*, L., Raugh*, I. M., & Strauss, G. P. (2022). Social media and internet use is associated with both adaptive and maladaptive changes in mental health during the COVID-19 pandemic in youth at clinical high-risk for psychosis. Journal of psychiatric research, 147, 1-3.

24.  Williams, T. F., Powers, A. R., Ellman, L. M., Corlett, P. R., Strauss,  G. P., Schiffman, J., Waltz, J. A., Silverstein, S. M., Woods, S. W.,  Walker, E. F., Gold, J. M., & Mittal, V. A (2022). Three  prominent self-report risk measures show unique and overlapping utility  in characterizing those at clinical high-risk for psychosis. Schizophrenia Research, 244, 58-65.

2021

1. Strauss, G.P. (2021). A Bioecosystem Theory of Negative Symptoms in Schizophrenia. Frontiers in Psychiatry, 12: 655471.

2.  Woods SW,Bearden CE, Sabb FW, Stone WS, Torous J, Cornblatt BA, Perkins  DO, Cadenhead KS, Addington J, Powers III AR, Mathalon DH, Calkins ME,  Wolf DH, Corcoran CM, Horton LE, Mittal VA, Schiffman JE, Ellman LE,  Strauss GP, Mamah D, Choi J, Pearlson GD, Shah JL, Fusar-Poli P, Arango  C, Perez J, Koutsouleris N, Wang J, Kwon JS, Walsh BC, McGlashan TH,  Hyman SE, Gur RE, Cannon TD, Kane JM, Anticevic A. (2021). Counterpoint.  Early intervention for psychosis risk syndromes: Minimizing risk and  maximizing benefit. Schizophrenia Research, 227, 10-17.

3.  Cohen, A. S., Schwartz, E. K., Le, T., Cowan, T. M., Kirkpatrick, B.,  Raugh*, I. M., Strauss, G.P. (2021). Digital phenotyping of negative  symptoms: The relationship to clinician ratings. Schizophrenia Bulletin, 23, 44-53.

4.  Gupta, T., Cowan, H.R., Strauss, G.P., Walker, E.F., Mittal, V.A.  (2021). Deconstructing negative symptoms in individuals at clinical  high-risk for psychosis: Evidence for volitional and diminished  emotionality subgroups that predict clinical presentation and functional  outcome. Schizophrenia Bulletin, 47, 54-63.

5.  Chang, W.C., Strauss, G.P., Ahmed, A.O., Wong, S.C.Y., Chan, J.K.N.,  Lee, E.H.M., Chan, S.K.W., Hui, C.L.M., James*, S.H., Chapman*, H.C.,  Chen, E.Y.H. (2021). The latent structure of negative symptoms in  individuals with attenuated psychosis syndromes and first episode  psychosis: Support for the 5 consensus domains. Schizophrenia Bulletin, 47, 386-394.

6.  Strauss, G.P., Bartolomeo, L.A., Harvey, P.D. (2021). Avolition as the  core negative symptom in schizophrenia: Relevance to pharmacological  treatment development. Npj Schizophrenia, 26: 16.

7.  Sun, J., Ka, ECW, Strauss, GP, Ahmed, AO, Chui WWH, Chow, JSY (2021).  Validation of the traditional script chinese version of the Brief  Negative Symptom Scale. Asian Journal of Psychiatry, 55,: 102522.

8. Strauss, G.P., Datta,  R., Armstrong, W., Raugh*, I.M., Kraguljac, N.V., Lahti, A.C. (2021).  Reinforcement learning abnormalities in the attenuated psychosis  syndrome and first episode psychosis. European Neuropsychopharmacology, 47, 11-19. 

9. Pelletier-Baldelli, A., Strauss, G.P.,  Kuhney, F.S., Chun, C., Gupta, T., Ellman, L.M., Schiffman, J., Mittal,  V.A. (2021). Perceived stress influences anhedonia and social  functioning in a community sample enriched for psychosis-risk. Journal of Psychiatric Research, 135, 96-103.

10.  Bartolomeo*, L.A., Chapman*, H.C., Raugh*, I.M., Strauss, G.P. (2021).  Delayed discounting in youth at clinical high-risk for psychosis and  adults with schizophrenia. Psychological Medicine, 51, 1898-1905.

11.  Clay, K. B., Raugh, I. M., Bartolomeo, L. A., & Strauss, G. P.  (2021). Defeatist performance beliefs in individuals at clinical  high‐risk for psychosis and outpatients with chronic schizophrenia.  Early Intervention in Psychiatry, 15(4), 865-873.

12.  Kirkpatrick, B., Cohen, A., Bitter, I., & Strauss, G. P. (2021).  Primary Negative Symptoms: Refining the Research Target. Schizophrenia  Bulletin, 47(5), 1207-1210.

13.  Buchanan RW, Kelly DL, Strauss GP, Gold JM, Weiner E, Zaranski J, Chen  S, Blatt F, Holden J, Granholm E. (2021). Combined Oxytocin and  Cognitive Behavioral Social Skills Training for Social Function in  People With Schizophrenia. Journal of Clinical  Psychopharmacology;41(3):236-43.

14.  Silverstein SM, Thompson JL, Gold JM, Schiffman J, Waltz JA, Williams  TF, Zinbarg RE, Mittal VA, Ellman LM, Strauss GP, Walker EF (2021).  Increased face detection responses on the mooney faces test in people at  clinical high risk for psychosis. npj Schizophrenia. 17;7(1):1-7.

15.  Strauss, G. P., Macdonald*, K. I., Ruiz*, I., Raugh*, I. M.,  Bartolomeo*, L. A., & James*, S. H. (2021). The impact of the  COVID-19 pandemic on negative symptoms in individuals at clinical  high-risk for psychosis and outpatients with chronic schizophrenia.  European Archives of Psychiatry and Clinical Neuroscience, 1-11.

16.  Mittal, V. A., Bernard, J. A., Strauss, G. P., & Walther, S.  (2021). New insights into sedentary behavior highlight the need to  revisit the way we see motor symptoms in psychosis. Schizophrenia  bulletin, 47(4), 877-879.

17.  Sabe, M., Zhao, N., Crippa, A., Strauss, G. P., & Kaiser, S.  (2021). Intranasal Oxytocin for Negative Symptoms of Schizophrenia:  Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of  Randomized Controlled Trials. International Journal of  Neuropsychopharmacology, 24(8), 601-614.

18.  Azis, M., Rouhakhtar, P. R., Schiffman, J. E., Ellman, L. M., Strauss,  G. P., & Mittal, V. A. (2021). Structure of positive psychotic  symptoms in individuals at clinical high risk for psychosis. Early  intervention in psychiatry, 15(3), 505-512.

19.  Strauss, G. P., Bartolomeo*, L. A., & Luther*, L. (2021). Reduced  willingness to expend effort for rewards is associated with risk for  conversion and negative symptom severity in youth at clinical high-risk  for psychosis. Psychological Medicine, 1-8.

20.  Raugh*, I. M., James*, S. H., Gonzalez*, C. M., Chapman*, H. C., Cohen,  A. S., Kirkpatrick, B., & Strauss, G. P. (2021). Digital  phenotyping adherence, feasibility, and tolerability in outpatients with  schizophrenia. Journal of Psychiatric Research, 138, 436-443.

21.  Gupta, T., Strauss, G. P., Cowan, H. R., Pelletier-Baldelli, A.,  Ellman, L. M., Schiffman, J., & Mittal, V. A. (2021). Secondary  Sources of Negative Symptoms in Those Meeting Criteria for a Clinical  High-Risk Syndrome. Biological Psychiatry Global Open Science, 1(3),  210-218.

22.  Mittal, V. A., Walker, E. F., & Strauss, G. P. (2021). The COVID-19  Pandemic Introduces Diagnostic and Treatment Planning Complexity for  Individuals at Clinical High Risk for Psychosis. Schizophrenia bulletin,  47(6), 1518-1523.

23.  Mittal, V. A., Ellman, L. M., Strauss, G. P., Walker, E. F., Corlett,  P. R., Schiffman, J., Woods, S. W., Powers, A. R., Silverstein, S. M.,  Waltz, J. A., Zinbarg, Z., Chen, S., Williams, T., Kenney, J., &  Gold, J. M. (2021). Computerized assessment of psychosis risk. Journal of Psychiatry and Brain Science, 6, Article e210011

2020

1.  Visser*, K.F., Chapman*, H.C., Ruiz*, I., Strauss, G.P. (2020). A  meta-analysis of self-reported anticipatory and consummatory pleasure in  the schizophrenia-spectrum. Journal of Psychiatric Research, 121, 68-81. 

2.  Chang WC, Westbrook A, Strauss GP, Chu AOK, Chong CSY, Siu CMW, Chan  SKW, Lee EMH, Hui CLM, Suen YM, Lo TL, Chen EYH (2020). Abnormal  cognitive effort allocation and its association with amotivation in  first episode psychosis. Psychological Medicine, 50, 2599-2609. 

3.  Zou, Y., Ni, K., Wang, Y., Yu, E., Lui, S.S., Zhou, F., Yang, H.,  Cohen, A.S., Strauss, G.P., Cheung, E.F.C., Chan, R.C.K. (2020).  Effort-Cost Computation in a Transdiagnostic Psychiatric Sample:  Differences Among Patients with Schizophrenia, Bipolar Disorder, and  Major Depressive Disorder. PsyCh Journal, 9, 2120-222. 

4.  Dwyer, K., Andrea, A., Savage, C., Orth, R., Shan, L., Strauss, G.P.,  Adams, H.A., Kelly, D.L., Weiner, E., Gold, J.M., McMahon, R.P.,  Carpenter, W.T., Buchanan, R.W., Blanchard, J. (2020). A randomized  clinical trial of oxytocin or galantamine in schizophrenia: Assessing  the impact on behavioral, lexical, and self-report indicators of social  affiliation. Schizophrenia Bulletin Open, 1, sgaa001.

5.  Jeakal, E., Park, K., Lee, E., Strauss, G.P., Choi, K.H. (2020).  Validation of the brief negative symptom scale in Korean samples with  schizophrenia. Asia Pacific Psychiatry, 12, e12382.

6.  Strauss, G.P., Zamani-Esfahlani*, F., Sayama, H., Kirkpatrick, B.,  Opler, M., Saoud, J.B., Davidson, M., Luthringer, R. (2020). Network  analysis indicates that avolition is the most central domain for the  successful treatment of negative symptoms: Evidence from the  roluperidone clinical trial. Schizophrenia Bulletin, 8, 964-970.

7. Strauss, G.P., Zamani-Esfahlani*,  Granholm, E., Holden, J., F., Visser*, K.H., Bartolomeo, L.A.*. Sayama,  H. (2020).. Mathematically modeling anhedonia in schizophrenia: A  stochastic dynamical systems approach. Schizophrenia Bulletin, 46,  1191-1201.

8.  Greene, H.H., Brown, J.M., Strauss, G.P. (2020). Shorter fixation  durations for up-directed saccades during saccadic exploration: A  meta-analysis. Journal of Eye Movement Research, 12, 10.16910.

9. Tatsumi, K., Kirkpatrick, B., Strauss, G. P., & Opler, M. (2020). The brief negative symptom scale in translation: A review of psychometric properties and beyond. European Neuropsychopharmacology, 33, 36-44.

10.  Cohen, A. S., Cowan, T. M., Le, T. P., Schwartz, E. K., Kirkpatrick,  B., Raugh*, I. M., Chapman*, H. C., Strauss, G. P. (2020). Ambulatory  digital phenotyping of blunted affect and alogia using objective facial  and vocal analysis: Proof of concept. Schizophrenia Research., 220, 141-146.

11.  Cowan, H.R., Mittal, V.A., Allen, D.N., Gold, J.M., Strauss, G.P.  (2020). Heterogeneity of emotional experience in schizophrenia: Trait  positive and negative affect clusters predict clinical presentation and  functional outcome. Journal of Abnormal Psychology, 129, 760-767.

12. Strauss, G.P., Pelletier-Baldelli, A., Visser*, K.F., Walker, E.F., Mittal, V.A.  (2020). A review of negative symptom assessment strategies in youth at  clinical high-risk for psychosis. Schizophrenia Research, 222, 104-112.

13.  Kafadar, E., Mittal, V.A., Strauss, G.P., Chapman*, H.C., Ellman, L.M.,  Bansal, S., Gold, J.M., Alderson-Day, B., Evans, S., Moffatt, J.,  Silverstein, S.M., Walker, E.F., Woods, S.W., Corlett, P.R., Powers,  A.R. (2020). Modeling perception and behavior in individuals at clinical  high-risk for psychosis: support for the predictive processing  framework. Schizophrenia Research, 226, 167-175. 

14.  Bartolomeo*, L.A., Culbreth*, A.J., Ossenfort*, K.L., Strauss, G.P.  (2020). 

Neurophysiological evidence for emotion regulation impairment in  schizophrenia: the role of visual attention and cognitive effort. Journal of Abnormal Psychology, 222, 104-112.

15.  Ruiz*, I., Raugh*, I.M., Bartolomeo*, L.A., Strauss, G.P. (2020). A  meta-analysis of neuropsychological effort test performance in psychotic  disorders. Neuropsychology Review, 30, 407-424.

16.  Gold, J.M, Corlett, P.R., Strauss, G.P., Schiffman, J., Ellman, L.M.,  Walker, E.F., Powers, A.R., Woods, S.W., Waltz, J.A., Silverstein, S.M.,  Mittal, V.A. (2020). Enhancing psychosis risk prediction through  computational cognitive neuroscience. Schizophrenia Bulletin, 46, 1346-1352. 

17.  Raugh*, I.M., Chapman*, H.C., Cohen, A.S., Kirkpatrick, B., Strauss,  G.P. (2020). Geolocation as a digital phenotyping measure of negative  symptoms and functional outcome. Schizophrenia Bulletin, 46, 1596-1607.

18. Cohen, A.S., Cox, C., Le, T., Cowan, T., Masucci, M., Strauss, G.P., Kirkpatrick, B. (2020). Using machine learning of computerized vocal expression to measure blunted vocal affect and alogia. Npj Schizophrenia, 6: 26.

19.  Chapman, H.C., Visser, K.H., Mittal, V.A., Gibb, B.E., Coles, M.E.,  Strauss, G.P. (2020). Emotion regulation across the psychosis continuum.  Development & Psychopathology, 32, 219-227.

2019

1.  Raugh*, I.M., Chapman*, H.C., Bartolomeo*, L.A., Gonzalez*, C., &  Strauss, G.P.​ (2019). A comprehensive review of psychophysiological  applications for ecological momentary assessment in psychiatric  populations. Psychological Assessment, 31, 304-317.

2. Cohen,  A.S., Schwartz, E. K., Le, T., Fedechko, T., Kirkpatrick, B., Strauss,  G.P. (2019). Using biobehavioral technologies to effectively advance  research on negative symptoms. World Psychiatry, 18, 103-104.

3. Azis,  M., Strauss, G.P., Walker, E.F., Revelle, W., Zinbarg, R., Mittal, V.A.  (2019). Factor analysis of negative symptom items on the Structured  Interview for Prodromal Syndromes. Schizophrenia Bulletin, 45, 1042-1050.

4. Strauss,  G.P., Ahmed, A.O., Young, J.A., Kirkpatrick, B. (2019). Reconsidering  the latent structure of negative symptoms in schizophrenia: A review of  evidence supporting the five consensus domains. Schizophrenia Bulletin, 45, 725-729.

5. Strauss, G.P., Esfahlani, F.Z., Kirkpatrick, B., Allen, D.N., Gold, J.M., Visser,  K.F., Sayama, H. (2019). Network analysis reveals which negative symptom  domains are most central in schizophrenia versus bipolar disorder. Schizophrenia Bulletin, 45, 1319-1330.

6.  Yee, C., Strauss, G.P., Allen, D.N, Haase, C., Kimhy, D., & Mittal,  V.A (2019). Trait emotional experience in individuals with  schizophrenia and youth at clinical high-risk for psychosis. BJPsych Open, 5, e78.

7.  Gupta, T., Haase, C.M., Strauss, G.P., Cohen, A.S., Mittal, V.A.  (2019). Alterations in facial expressivity in youth at clinical  high-risk for psychosis. Journal of Abnormal Psychology, 128, 341-351.

8.  Lee, M.R., Wehring, H.J., McMahon, R.P., Liu, F., Linthicum, J.,  Buchanan, R.W., Strauss, G.P., Rubin, L., Kelly, D.M. (2019). The effect  of intranasal oxytocin on social cognition measures in schizophrenia: A  negative report. Journal of Psychiatry and Brain Science, 4,(1)pii e190001.

9.  Bartolomeo*, L.A., Erickson, M.A., Arnold*, L.E., Strauss, G.P. (2019).  Frontal Alpha Asymmetry in Youth at Clinical High-Risk for Psychosis. Current Behavioral Neuroscience Reports, 6, 21-26.

10.  Strauss, G.P., Chapman*, H.C., Keller, W.R., Koenig, J.I., Gold, J.M.,  Carpenter, W.T., Buchanan, R.W. (2019). Endogenous oxytocin levels are  associated with impaired social cognition and neurocognition in  schizophrenia. Journal of Psychiatric Research, 112, 38-43.

11.  Strauss, G.P., Granholm, E., Holden, J.L., Ruiz*, I., Gold, J.M.,  Kelly, D.L., Buchanan, R.W. 

(2019). The combined effects of oxytocin and  cognitive behavioral social skills training on social cognition in  schizophrenia. Psychological Medicine, 49, 1731-1739.

12.  Strauss, G.P., Zamani Esfahlani, F., Galderisi, S., Mucci, A., Rossi,  A., Bertolino, A., Rocca, P., Maj, M., Kirkpatrick, B., Ruiz, I.,  Sayama, H. (2019). Network analysis reveals latent dimensions of  negative symptoms in schizophrenia. Schizophrenia Bulletin, 45, 1033-1041.

13.   Strauss, G. P., Zamani Esfahlani, F.,  Visser, K. F., Dickinson, E.  K., Gruber, J., & Sayama, H. (2019).  Mathematically Modeling  Emotion Regulation Abnormalities During  Psychotic Experiences in  Schizophrenia. Clinical Psychological Science, 7(2), 216-233.

14.  Ahmed,  A.O., Kirkpatrick, B., Galderisi, S., Mucci, A., Rossi, A., Bertolino,  A., Rocca, P., Maj, M., Kaiser, S., Bischof, M., Hartmann-Riemer, M.N.,  Kirschner, M., Schneider, K., Garcia-Portilla, M.P., Mane, A., Bernardo,  M., Fernandez-Egea, E., Jiefeng, C, Jing, Y, Shuping, T., Gold, J.M.,  Allen, D.N., Strauss, G.P. (2019). Cross-cultural validation of the  five-factor model of negative symptoms in schizophrenia. Schizophrenia Bulletin, 45, 305-314.

15.  Vargas, T., Ahmed, A., Strauss, G.P., Brandes, C.M., Walker, E., Gold,  J., Buchanan, R., Mittal, V. (2019) The Latent Structure of Depressive  Symptoms Across Clinical High Risk and Chronic Phases of Psychotic  Illness. Translational Psychiatry, 9, 229. 

16. Chang, W.C., Chu, O.A., Treadway, M.T., Strauss,  G.P., Chan, S.K., Lee, E.H., Hui, C.L., Suen, Y.N., Chen, E.Y. (2019)  Effort-based decision-making impairment in patients with  clinically-stabilized first-episode psychosis and its relationship with  amotivation and psychosocial functioning. European Neuropsychophamracology, 29, 629-642.

2018

1.  Strauss, G.P., Chapman*, H.C. (2018). Preliminary Psychometric  Properties of the Brief Negative Symptom Scale in Youth at Clinical  High-Risk for Psychosis. Schizophrenia Research, 193, 435-437.

2.  Strauss, G.P., Raugh*, I.M., Mittal, V.A., Gibb, B.E., Coles, M.E.  (2018). Bullying victimization and perpetration in a community sample of  youth with psychotic like experiences. Schizophrenia Research, 195, 534-536.

3.  Gruber, J.M., Strauss, G.P., Dombrecht, L., Mittal, V.A. (2018).  Neuroleptic-free youth at ultrahigh risk for psychosis evidence  diminished emotion reactivity that is predicted by depression and  anxiety. Schizophrenia Research, 193, 428-434.

4.  Ahmed, A.O., Strauss, G.P., Buchanan, R.W., Kirkpatrick, B., Carpenter,  W.T. (2018). Schizophrenia heterogeneity revisited: Clinical,  cognitive, and psychosocial correlates of statistically-derived negative  symptoms subgroups. Journal of Psychiatric Research, 97, 8-15.

5. Strauss, G.P., Cohen, A.S. (2018). The schizophrenia-spectrum anhedonia paradox. World Psychiatry, 17, 221-222.

6.  Galderisi, S., Rucci, P., Kirkpatrick, B., Mucci, A., Gibertoni, D.,  Rocca, P., Rossi, A., Bertolino, A., Strauss, G.P., Aguglia, E.,  Bellomo, A., Belvederi Murri, M., Bucci, P., Carpiniello, B.,  Comparelli, A., Cuomo, A., De Berardis, D., Dell’Osso, L., Di Fabio, F.,  Gelao, B., Marchesi, C., Monteleone, P., Montemagni, C., Orsenigo, G.,  Pacitti, F., Roncone, R., Santonastaso, P., Siracusano, A, Vignapiano,  A., Vita, A., Zeppegno, P., Maj, M. (2018). A network analysis of the  interplay among psychopathology, personal resources, context-related  factors and real-life functioning in schizophrenia. JAMA Psychiatry, 75, 396-404.

7.   Li, Y., Li, W.X., Zou, Y.M., Yang, Z.Y., Xie, D.J., Yang, Y., Lui,  S.S., Strauss, G.P., Cheung, E.F., Chan, R.C. (2018). Revisiting the  persistent negative symptoms proxy score using the Clinical Assessment  Interview for Negative Symptoms. Schizophrenia Research, 202, 248-253.

8.  Strauss, G.P., Nunez, A., Ahmed, A.O., Barchard, K.A., Granholm, E.,  Kirkpatrick, B., Gold, J.M., Allen, D.N. (2018). The latent structure of  negative symptoms in schizophrenia. JAMA Psychiatry, 75, 1271-1279.

9.  Vargas,  T., Snyder, H., Newberry, R., Shankman, S.A., Strauss, G.P., Mittal.  V.A., (2018). Altered selection during language processing in  individuals at high risk for psychosis. Schizophrenia Research, 202, 303-309.

10. Yang,  Y., Yang, Z.Y., Zou, Y.M., Shi,  H.S., Wang, Y., Xie, D.J., Zhang,  R.T., Lui, S.S., Cohen, A.C., Strauss,  G.P. and Cheung, E.F., (2018).  Low-pleasure beliefs in patients with  schizophrenia and individuals  with social anhedonia. Schizophrenia research, 201, 137-144.

11. Goldsmith,  D.R., Haroon, E., Miller, A.H., Strauss, G.P., Buckley, P.J., Miller,  B.J. (2018). TNF and IL-6 are Associated with the Deficit Syndrome and  Negative Symptoms in Patients with Chronic Schizophrenia. Schizophrenia Research, 199, 281-284.

12. Wehring,  H.J., Buchanan, R.W., Feldman, S., Carpenter, W.T., McMahon, R.P.,  Weiner, E., Gold, J.M., Adams, H.A., Strauss, G.P., Rubin, L.H. and  Kelly, D.L. (2018). Oxytocin and sexual function in males and females  with schizophrenia. Schizophrenia Research, 199, 431-432.

13.  Visser*, K.H., Zamani-Esfahlani*, F., Sayama, H., Strauss, G.P. (2018).  An ecological momentary assessment evaluation of emotion regulation  abnormalities in schizophrenia. Psychological Medicine, 48, 2337-2345.

14.  Ellenberg, S., Lynn, S. J., & Strauss, G. P. (2018). Psychotherapy for Schizophrenia‐Spectrum Disorders. Evidence‐Based Psychotherapy: The State of the Science and Practice, 363-405.

15.   Strauss, G. P., Ruiz, I., Dickinson,  E. K., & Visser, K. H.  (2018). The Role of Negative Emotion  Abnormalities in Anhedonic  Symptoms of Schizophrenia. In Neurobiology of Abnormal Emotion and Motivated Behaviors (pp. 258-276).

16.   Esfahlani, F. Z., Visser, K., Strauss,  G. P., & Sayama, H.  (2018). A network-based classification  framework for predicting  treatment response of schizophrenia patients. Expert Systems with Applications, 109, 152-161.

17.  Maxwell, R., Lynn, S. J., &  Strauss, G. P. (2018). Trait Emotion  Regulation Predicts Individual  Differences in Momentary Emotion and  Experience. Imagination, Cognition and Personality, 0276236618781775. 

18.  Stewart, E., Gibb, B.E., Strauss,  G.P., & Coles, M.E. (2018). Disruptions in the amount and timing of  sleep and repetitive negative thinking in adolescents. Behavioral Sleep Medicine, 1-9. 

19.  Kirkpatrick, B., Saoud, J.B., Strauss, G.P., Ahmed, A.O., Tatsumi, K.,  Opler, M., Luthringer, R., Davidson, M. (2018). The Brief Negative  Symptom Scale (BNSS): Sensitivity to Treatment Effects. Schizophrenia Research, 197, 279-273.

20.  Strauss, G.P., Visser*, K.H., Keller, W.R., Gold, J.M., Buchanan, R.W.  (2018). Anhedonia reflects impairment in making relative value judgments  between positive and neutral stimuli in schizophrenia. Schizophrenia Research, 197, 156-161.

2017

1.  Cohen, A.S., Mitchell, K.R., Strauss, G.P., Blanchard, J.J., Buchanan,  R.W., Kelly, D.L., Gold, J.M., McMahon, R.P., Adams, H. A., Carpenter,  W.T. (2017). The effects of oxytocin and galantamine on objectively  defined vocal and facial expressions: Data form the CIDAR study.  Schizophrenia Research, 188, 141-143. 

2.  Sullivan*, S.K., Strauss, G.P. (2017). Electrophysiological evidence  for detrimental impact of a reappraisal emotion regulation strategy on  subsequent cognitive control in schizophrenia. Journal of Abnormal Psychology, 125(5), 679-693. 

3. Strauss, G.P., Cohen, A.S. (2017). A transdiagnostic review of negative symptom phenomenology and etiology. Schizophrenia Bulletin, 43 (4), 712-719. 

4. Strauss, G.P., Frost*, K.H., Lee*, B.G., Gold, J.M. (2017). The positivity offset theory of anhedonia in schizophrenia. Clinical Psychological Science, 5(2) 226-238. 

5.  Buchanan, R.W., Kelly, D.L., Weiner, E., Gold, J.M., Strauss, G.P.,  Koola, M.M., McMahon, R.P., Carpenter, W.T. (2017). A Randomized  Clinical Trial of Oxytocin and Galantamine for the Treatment of Negative  Symptoms and Cognitive Impairments in People with Schizophrenia. Journal of Clinical Psychopharmacology, 37(4), 394-400.  

6.  Pellettier-Baldelli, A., Strauss, G.P., Visser*, K.H., Mittal, .A.  (2017). Initial development and preliminary psychometric properties of  the Prodromal Inventory of Negative Symptoms. Schizophrenia Research, 189, 43-49. 

7.   Strauss, G.P., Ruiz*, I., Visser*, K.H, Crespo*, L.P., Dickinson*,  E.K. (in press). Diminished hedonic response in neuroleptic-free youth  at ultra-high-risk for psychosis. Schizophrenia Research: Cognition.

8.   Esfahlani, F. Z., Sayama, H., Visser,  K. F., & Strauss, G. P.  (2017). Sensitivity of the Positive And  Negative Syndrome Scale (PANSS)  in detecting treatment effects via  network analysis. Innovations in clinical neuroscience, 14(11-12), 59.
 

2016

1.  Strauss, G.P., Gold, J.M. (2016). A psychometric comparison of the  Clinical Assessment Interview for Negative Symptoms (CAINS) and the  Brief Negative Symptom Scale (BNSS). Schizophrenia Bulletin, 42, 1384-1394.   
 

2.  Bischof, M., Obermann, C., Hartmann, M.N., Hager, O.M., Kirschner, M.,  Kluge, A., Strauss, G.P., Kaiser, S. (2016). The Brief Negative Symptom  Scale: Validation of the German translation and convergent validity with  self-rated anhedonia and observer-rated apathy. BMC Psychiatry, 16,  415.  
 

3. Strauss, G.P., Ossenfort*, K.L., Whearty*, K. M. (2016). Reappraisal  and distraction emotion regulation strategies are associated with  distinct patterns of visual attention. PlosOne, 11, e0162290.
 

4. Frost*, K.H., Strauss, G.P. (2016). A review of anticipatory pleasure in schizophrenia. Current Behavioral Neuroscience Reports, 3, 232-247.
 

5. Lee, M.R ., Wehring, H.J., McMahon, R.P., Liu, F., Linthicum, J.,  Verbalis, J.G., Buchanan, R.W., Strauss, G.P., Rubin, L.H.,. Kelly, D.L  (2016). Relationship of plasma oxytocin levels to baseline symptoms and  symptom changes during three weeks of daily oxytocin administration in  people with schizophrenia. Schizophrenia Research, 172, 165-168.  
 

6. Morra*, L.F., Strauss, G.P. (2016). The effects of hypertension on the generalized neurocognitive deficit in schizophrenia. Schizophrenia Research, 176, 527-528.  
 

7. Strauss, G.P., Whearty*, K.M., Morra*, L.F., Sullivan*, S.K.,  Ossenfort*, K.L., Frost*, K.H. (2016). Avolition in schizophrenia is  associated with reduced willingness to expend effort for reward on a  progressive ratio task. Schizophrenia Research, 170, 198-204.  
 

8. Strauss, G.P., Vertinski, M., Vogel, S.J., Ringdahl, E.N., Allen,  D.N. (2016). Negative symptoms in bipolar disorder and schizophrenia: A  psychometric evaluation of the Brief Negative Symptom Scale across  diagnostic categories. Schizophrenia Research, 170, 285-289.  
 

9. Cohen, A.S., Callaway, D.A., Mitchell, K.R., Larsen, J.T., Strauss,  G.P. (2016). A temporal examination of co-activated valence networks in  schizophrenia and schizotypy. Schizophrenia Research, 170, 322-329.  
 

10. Strauss, G.P., Frost*, K.H., Whearty, K.M., Carpenter, W.T. (2016). A  translational affective neuroscience model of approach motivation in  schizophrenia. Nebraska Symposium on Motivation, 63, 159-203.  
 

11. Carpenter, W.T., Whearty*, K.M., Frost*, K.H., Strauss, G.P. (2016).  Avolition, negative symptoms, and a clinical science journey and  transition to the future. Nebraska Symposium on Motivation, 63, 133-158.    

2015 

1.  Strauss, G.P., Thaler, N.S., Matveeva, T.M., Vogel, S.J., Sutton, G.P.,  Lee, B.G., Allen, D.N. (2015). Predicting psychosis across diagnostic  boundaries: Behavioral and computational modeling evidence for impaired  reinforcement learning in schizophrenia and bipolar disorder with a  history of psychosis. Journal of Abnormal Psychology, 124, 697-708.  
 

2.  Whearty*, K.M., Allen, D.N., Lee, B.G., Strauss, G.P. (2015). The  evaluation of insufficient cognitive effort in schizophrenia in light of  low IQ scores. Journal of Psychiatric Research, 68, 397-404.  
 

3. Ahmed, A.A., Strauss, G.P., Buchanan, R.W., Kirkpatrick, B.,  Carpenter, W.T. (2015). Are Negative Symptoms Dimensional or  Categorical? Detection and Validation of Deficit Schizophrenia with  Taxometric and Latent Variable Mixture Models. Schizophrenia Bulletin, 41, 879-891.
 

4. Strauss, G.P., Kappenman, E.S., Culbreth, A.J., Catalano, L.T.,  Ossenfort*, K.L., Lee, B.G., Gold, J.M. (2015). Emotion regulation  abnormalities in schizophrenia: Directed attention strategies fail to  decrease the neurophysiological response to unpleasant stimuli. Journal of Abnormal Psychology, 124, 288-301.
 

5. Morra*, L.F., Gold, J.M., Sullivan*, S.K. Strauss, G.P. (2015).  Predictors of neuropsychological effort test performance in  schizophrenia. Schizophrenia Research, 162, 205-210.  
 

6. Strauss, G.P., Morra*, L.F., Sullivan*, S.K., Gold, J.M. (2015). The  role of low cognitive effort and negative symptoms in neuropsychological  impairment in schizophrenia. Neuropsychology, 29, 282-291.
 

7. Strauss, G.P., Keller, W.R., Koenig, J.I., Frost*, K.H., Gold, J.M.,  Buchanan, R.W. (2015). Plasma oxytocin levels predict social cue  recognition in individuals with schizophrenia. Schizophrenia Research, 162, 47-51.
 

8. Strauss, G.P., Keller, W.R., Koenig, J.I., Sullivan*, S.K., Gold,  J.M., Buchanan, R.W. (2015). Endogenous oxytocin levels are associated  with the perception of emotion in dynamic body expressions in  schizophrenia. Schizophrenia Research, 162, 52-56.
 

9. Strauss, G.P., Keller, W.R., Koenig, J.I., Gold, J.M., Ossenfort*,  K.L., Buchanan, R.W. (2015). Plasma oxytocin levels predict olfactory  identification and negative symptoms in individuals with schizophrenia. Schizophrenia Research, 162, 57-61.  
 

10. Coles, M.E., Strauss, G.P. (2015). Shedding light on tics. Psychiatry Research, 225, 743.  
 

11. Strauss, G. P., Culbreth, A. J.(2015). Assessing Psychosis in African American Clients. In Guide to Psychological Assessment with African Americans (pp. 247-259). Springer New York.    

2014   

1. Strauss, G.P., Waltz, J.A., Gold, J.M. (2014). A review of reward processing and motivational impairment in schizophrenia. Schizophrenia Bulletin, 40 (Suppl. 2), S107-116.  
 

2. Kiwanuka, J.N., Strauss, G.P., McMahon, R.P., Gold, J.M. (2014).  Psychological predictors of functional outcome in people with  schizophrenia. Schizophrenia Research, 157, 299-304.  
 

3. Keller, W.R., Vidal, C., Park E.S., Strauss, G.P., Fischer, B.F. (2014). The Risk of Diabetes in Deficit Schizophrenia. Clinical Schizophrenia & Related Psychoses, 7, 235-237.  
 

4. Strauss, G.P. (2014). Anhedonia in schizophrenia: A deficit in  translating reward information into motivated behavior. In M.S. Ritsner  (Eds.). Anhedonia: A Comprehensive Handbook Volume II. New York, NY: Springer, Publishing. 

2013 

1.  Barney-Vogel, S.J., Strauss, G.P., Verbiest, R., Allen, D.N. (2013).  Using negative feedback to guide behavior: Impairments on the first four  cards of the Wisconsin Card Sorting Test predicts negative symptoms of  schizophrenia. Schizophrenia Research, 151, 97-101.  
 

2.  Brown, J.K., Waltz, J.A., Strauss, G.P., McMahon, R.P., Frank, M.J.,  Gold, J.M. (2013). Hypothetical decision making in schizophrenia: The  role of expected value computation and “irrational” biases. Psychiatry Research, 209, 142-149.  
 

3. Strauss, G.P., & Allen, D.N. (2013). Emotional Verbal Learning Test: Psychometric Properties and Test Development. Archives of Clinical Neuropsychology, 28, 435-451.  
 

4. Strauss, G.P., Kappenman, E.S., Culbreth, A.J., Catalano, L.T., Lee,  B.G., Gold, J.M. (2013). Emotion Regulation Abnormalities in  Schizophrenia: Cognitive Change Strategies Fail to Decrease the Neural  Response to Unpleasant Stimuli. Schizophrenia Bulletin, 39, 872-883.  
 

5. Strauss, G.P., Catalano, L.T., Llerena, K., Gold, J.M. (2013). The  Processing of Emotional Stimuli during Periods of Limited Attentional  Resources in Schizophrenia. Journal of Abnormal Psychology, 122, 492-505.  
 

6. Gold, J.M., Strauss, G.P., Waltz, J.A., Robinson, B.M., Brown, J.K.,  Frank, M.J. (2013). Negative Symptoms of Schizophrenia are Associated  with Abnormal Effort-Cost Computations. Biological Psychiatry, 74, 130-136.  
 

7. Thaler, N.S., Allen, D.N., Sutton, G.P., Vertinski, M., Ringdahl,  E.N., Strauss, G.P. (2013). Emotion perception abnormalities across  sensory modalities in bipolar disorder with psychotic features and  schizophrenia. Schizophrenia Research, 149, 287-292.  
 

8. Strauss, G.P. (2013). Translating basic emotion research into novel psychosocial interventions for anhedonia. Schizophrenia Bulletin, 39, 737-739.  
 

9. Strauss, G.P. (2013). The emotion paradox of anhedonia in schizophrenia: Or is it? Schizophrenia Bulletin, 39, 247-250.  
 

10. Strauss, G.P., Horan, W.P., Kirkpatrick, B, Fischer, B.A., Keller,  W.R., Miski, P., Buchanan, R.W., Green, M.F., Carpenter, W.T. (2013).  Deconstructing negative symptoms of schizophrenia: Avolition-apathy and  emotional expression clusters predict clinical presentation and  functional outcome. Journal of Psychiatric Research, 47, 783-790.
 

11. Allen, D.N., Strauss, G.P., Barchard, K. A., Vertinski, M.,  Carpenter, W.T., Buchanan, R.W. (2013). Differences in Developmental  Changes in Academic and Social Premorbid Adjustment between Males and  Females with Schizophrenia. Schizophrenia Research, 146, 132-137.  
 

12. Lee, M.R., Wehring, H.J., McMahon, R.P., Linthicum, J., Cascella,  N., Liu, F., Bellack, A., Buchanan, R.W., Strauss, G.P., Contoreggi, C.,  Kelly, D.L. (2013). Adjunctive Intranasal Oxytocin in Schizophrenia  Patients Improves Olfactory Identification and Negative Symptoms in a  Context Dependent Manner: Results from a Double Blind Placebo Controlled  Pilot Study. Schizophrenia Research, 145, 110-115.    

2012   

1.  Strauss, G.P., Keller, W.R., Buchanan, R.W., Gold, J.M., Fischer, B.A.,  McMahon, R.P., Catalano, L.T., Culbreth, A.J., Carpenter, W.T.,  Kirkpatrick, B. (2012). Next-Generation Negative Symptom Assessment for  Clinical Trials: Validation of the Brief Negative Symptom Scale. Schizophrenia Research, 142, 88-92.  
 

2. Strauss, G.P., Hong, L.E., Keller, W.R., Buchanan, R.W., Gold, J.M.,  Fischer, B.A., McMahon, R.P., Catalano, L.T., Culbreth, A.J., Carpenter,  W.T., Kirkpatrick, B. (2012). Factor Structure of the Brief Negative  Symptom Scale. Schizophrenia Research, 142, 96-98.  
 

3. Llerena, K., Strauss, G.P., Cohen, A.S. (2012). Looking at the other  side of the coin: A meta-analysis of self-reported emotional arousal in  individuals with schizophrenia. Schizophrenia Research, 142, 65-70.  
 

4. Strauss, G.P., Lee, B.G., Waltz, J.A., Robinson, B.M., Brown, J.K.,  Gold, J.M. (2012). Cognition-Emotion Interactions are Modulated by  Working Memory Capacity in Individuals with Schizophrenia. Schizophrenia Research, 141, 257-261.  
 

5. Strauss, G.P., Sandt, A.R., Catalano, L.T., Allen, D.N. (2012).  Negative symptoms and depression predict psychological well-being in  individuals with schizophrenia. Comprehensive Psychiatry, 53, 1137-1144.  
 

6. Strauss, G.P., Gold, J.M., Cohen, A.S. (2012). Anticipatory and  consummatory pleasure deficits across the schizophrenia spectrum. Psychiatry Research, 198, 174-175.  
 

7. Cohen, A.S., Callaway, D., Najolia, G.M., Larsen, J., Strauss, G.P.  (2012). On “risk” and reward: state anhedonia in  psychometrically-defined schizotypy but not schizophrenia. Journal of Abnormal Psychology, 121, 407-415.  
 

8. Gold, J.M., Waltz, J.A., Matveeva, T.M., Kasanova, Z, Strauss, G.P.,  Herbener, E.S., Collins, A.G.E., Frank, M.J. (2012). Negative symptoms  in schizophrenia result from a failure to represent the expected value  of rewards: Behavioral and computational modeling evidence. Archives of General Psychiatry, 69, 129-138.  
 

9. Strauss, G.P., & Gold, J.M. (2012). A New Perspective on Anhedonia in Schizophrenia. American Journal of Psychiatry, 169, 364-373.  
 

10. Strauss, G.P., Allen, D.N., Miski, P., Kirkpatrick, B., Buchanan,  R.W., Carpenter, W.T. (2012). Differential patterns of premorbid  academic and social deterioration in deficit and non-deficit  schizophrenia. Schizophrenia Research, 135, 134-138. 

2011 

1.  Strauss, G.P., Robinson, B.M., Waltz, J.A., Frank, M.J., Kasanova, Z.,  Herbener, E.S., Gold, J.M. (2011). Patients with Schizophrenia  Demonstrate Inconsistent Preference Judgments for Affective and  Non-Affective Stimuli. Schizophrenia Bulletin, 37, 1295-1304.  
 

2. Barney, S.J., Allen, D.N., Thaler, N.S., Park, B.S., Strauss, G.P.,  Mayfield, J. (2011). Neuropsychological and Behavioral Measures of  Attention Assess Different Constructs in Children With Traumatic Brain  Injury. The Clinical Neuropsychologist, 25, 1145-1157.  
 

3. Strauss, G.P., Llerena, K., Gold, J.M. (2011). Attentional Disengagement from Emotional Stimuli in Schizophrenia. Schizophrenia Research, 131, 219-223.  
 

4. Strauss, G.P., Herbener, E.S. (2011). Patterns of Emotional  Experience in Schizophrenia: Differences in Emotional Response to Visual  Stimuli are Associated with Clinical Presentation and Functional  Outcome. Schizophrenia Research, 128, 117-123.  
 

5. Strauss, G.P., Wilbur, R.C., Warren, K.R., August, S.M., Gold, J.M.  (2011). Anticipatory vs. Consummatory Pleasure: What is the Nature of  Hedonic Deficits in Schizophrenia? Psychiatry Research, 187, 36-41.  
 

6. Kasanova, Z., Waltz, J.A., Strauss, G.P., Frank, M.J., Gold, J.M.  (2011). Optimizing vs. Matching: Response strategy in a probabilistic  learning task is associated with negative symptoms of schizophrenia. Schizophrenia Research, 127, 215-222.  
 

7. Strauss, G.P., Duke, L.A., Ross, S.A., Allen, D.N. (2011).  Posttraumatic Stress Disorder and Negative Symptoms of Schizophrenia. Schizophrenia Bulletin, 37, 603-610.
 

8. Kirkpatrick, B., Strauss, G.P., Nguyen, L., Fischer, B.F., Daniel,  D., Cienfuegos, A., Marder, S.R. (2011). The Brief Negative Symptom  Scale: Psychometric Properties. Schizophrenia Bulletin, 37, 300-305.  
 

9. Strauss, G.P., Frank, M.F., Waltz, J.A., Kasanova, Z., Herbener,  E.S., Gold, J.M. (2011). Deficits in Positive Reinforcement Learning and  Uncertainty-Driven Exploration are Associated with Distinct Aspects of  Negative Symptoms in Schizophrenia. Biological Psychiatry, 69, 424-431.    

2010 

1. Duke, L.A., Allen, D.N., Ross, S.A., Strauss, G.P. (2010). Neurocognitive Impairment in Schizophrenia with Comorbid PTSD. Journal of Clinical and Experimental Neuropsychology, 32, 737-751.  
 

2. Strauss, G.P., Allen, D.N., Ross, S.A., Duke, L.A., Schwartz, J.  (2010). Olfactory hedonic judgment in patients with deficit syndrome  schizophrenia. Schizophrenia Bulletin, 36, 860-868.  
 

3. Strauss, G.P., Harrow, M., Grossman, L.S., Rosen, C. (2010). Periods  of Recovery in Deficit Syndrome Schizophrenia: A 20-Year Multifollowup  Longitudinal Study. Schizophrenia Bulletin, 36, 788-799.  
 

4. Strauss, G.P., Jetha, S.S., Duke, L.A., Ross, S.A., Allen, D.N.  (2010) Impaired Facial Affect Labeling and Discrimination in Patients  with Deficit Syndrome Schizophrenia. Schizophrenia Research, 118, 146-153.    

2009 

1.  Gold, J.M., Hahn, B., Strauss, G.P., Waltz, J.A. (2009). Turning it  Upside Down: Areas of Preserved Cognitive Function in Schizophrenia. Neuropsychology Review, 19 (3), 294-311.  
 

2. Strauss, G.P., Allen, D.N. (2009). Positive and negative emotions uniquely capture attention. Applied Neuropsychology, 16, 144-149.              

2008 

1.  Grossman, L.S., Harrow, M., Rosen, C., Faull, R., Strauss, G.P. (2008).  Sex Differences in Schizophrenia and Other Psychotic Disorders: A  20-Year Longitudinal Study of Psychosis and Recovery. Comprehensive Psychiatry, 49, 523-529.  
 

2. Strauss, G.P., Allen, D.N., Duke, L.A., Ross, S.A, Schwartz, J.  (2008). Automatic affective processing impairments in patients with  deficit syndrome schizophrenia. Schizophrenia Research, 102, 76-87.  
 

3. Lykins, A.D., Meana, M., & Strauss, G.P. (2008). Gender differences in visual attention to erotic stimuli. Archives of Sexual Behavior, 37, 219-228.  
 

4. Schwanenflugel, P.J., Morris, R.D., Kuhn, M.R., Strauss, G.P.,  Sieczko, J.M. (2008). The influence of reading unit size on the  development of Stroop interference in early word decoding. Reading and Writing: An Interdisciplinary Journal, 21, 177-203.  
 

5. Strauss, G. P., & Allen, D. N. (2008). Emotional intensity and  categorization ratings for emotional and nonemotional words. Cognition & Emotion, 22(1), 114-133.  
 

6. Allen D.N., Strauss G.P., Leany B.D., & Donohue B. (2008).  Neuropsychological Assessment of Individuals with Substance Use  Disorders. In A.M. Horton & D. Wedding (Eds.), The Neuropsychology Handbook, 3rd Edition. Springer Publishing Company: New York.                               

2007

 1. Allen, D.N., Strauss, G.P., Kemtes, K.A., Goldstein, G. (2007). Hemispheric contributions to spatial problem solving. Neuropsychology, 21, 713-720.  
 

2. Allen, D.N., Strauss, G.P., Donohue, B., & van Kammen, D.P.  (2007). Factor analytic support for social cognition as a separable  cognitive domain in schizophrenia. Schizophrenia Research, 93, 325-333.      

2006 

1.  Schwanenflugel, P.J., Meisinger, E., Wisenbaker, J.M., Kuhn, M.R.,  Strauss, G.P. & Morris, R.D. (2006). Becoming a fluent and automatic  reader in the early elementary school years. Reading Research Quarterly, 41, 496-522.  
  

2. Strauss, G. P., & Allen, D. N. (2006). The experience of positive emotion is associated with the automatic processing of positive emotional words. Journal of Positive Psychology, 1 (3), 150-159.  

3. Strauss, G. P., Allen, D. N., Jorgensen, M. L., & Cramer, S. L. (2005). Test-Retest reliability in Stroop and Emotional Stroop Tasks: An investigation of color-word and picture-word versions. Assessment, 12 (3), 330-337.  

4. Allen, D. N., Frantom, L.V., Strauss, G.P., & van Kammen, D.P. (2005). Differential patterns of premorbid academic and social deterioration in patients with schizophrenia. Schizophrenia Research, 75, 389-397.